Two doses of a new immunotherapy cleared a child's liver cancer.
Researchers at Texas Children's, Baylor College of Medicine and Seattle Children's reported in the New England Journal of Medicine that a child with hepatoblastoma had complete regression of disease after a novel immunotherapy given as part of the CARE study.
THE SCAN CAME BACK EMPTY.
A child treated on the CARE study had complete regression of liver cancer after a novel immunotherapy, reported in the New England Journal of Medicine by Texas Children's, Baylor College of Medicine and Seattle Children's.
WHAT HAPPENED
Texas Children's announced in September 2026 that a report in the New England Journal of Medicine, from researchers at Texas Children's, Baylor College of Medicine and Seattle Children's, describes complete regression of liver cancer in a child treated with a novel immunotherapy as part of the CARE study.
WHY THIS IS HOPESLOP
One case is one case. But a hepatoblastoma that disappears is the kind of result that turns an experimental idea into a next trial, and the next trial into a standard of care. Somewhere there is a family whose scans came back with nothing on them.
ORIGINAL SOURCETexas Children's HospitalRead the original report
A DAILY ALLEGATION OF PROGRESS.
One good thing from the internet, every day. Nothing else.
MORE HOPESLOP
The first 1,000 native trees took root along the Guadalupe River.
The locally collected seedlings begin a five-year, 50,000-tree recovery plan.
Two Kauaʻi state parks reopened after two months of hurricane repairs.
Major lookouts and several trails are open again, though repairs and closures continue.
Virginia voters approved an equal-marriage amendment.
The result reverses a 2006 state constitutional ban; certification is still pending.